Schonfeld Strategic Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-213,861
| Closed | -$1.04M | – | 2028 |
|
|
2025
Q1 | $1.04M | Buy |
213,861
+67,949
| +47% | +$330K | 0.01% | 1159 |
|
|
2024
Q4 | $1.39M | Buy |
+145,912
| New | +$1.39M | 0.01% | 930 |
|
|
2024
Q1 | – | Sell |
-27,200
| Closed | -$65.3K | – | 1951 |
|
|
2023
Q4 | $65.3K | Buy |
+27,200
| New | +$65.3K | ﹤0.01% | 1564 |
|
|
2023
Q1 | – | Sell |
-51,400
| Closed | -$607K | – | 2124 |
|
|
2022
Q4 | $607K | Buy |
+51,400
| New | +$607K | 0.01% | 1409 |
|
|
2020
Q4 | – | Sell |
-6,600
| Closed | -$682K | – | 1590 |
|
|
2020
Q3 | $682K | Buy |
+6,600
| New | +$682K | 0.01% | 780 |
|
|
2020
Q2 | – | Sell |
-8,376
| Closed | -$485K | – | 1271 |
|
|
2020
Q1 | $485K | Buy |
+8,376
| New | +$485K | 0.03% | 593 |
|
|
2019
Q3 | – | Sell |
-27,200
| Closed | -$1.32M | – | 1051 |
|
|
2019
Q2 | $1.32M | Buy |
+27,200
| New | +$1.32M | 0.05% | 379 |
|
|
2018
Q3 | – | Sell |
-12,000
| Closed | -$605K | – | 830 |
|
|
2018
Q2 | $605K | Buy |
12,000
+6,009
| +100% | +$303K | 0.03% | 496 |
|
|
2018
Q1 | $316K | Buy |
+5,991
| New | +$316K | 0.02% | 582 |
|